Found: 2
Select item for more details and to access through your institution.
Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airlow limitation: the GEMI study.
- Published in:
- International Journal of COPD, 2016, v. 11, p. 1233
- By:
- Publication type:
- Article
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 4, p. 417, doi. 10.1164/rccm.202303-0458OC
- By:
- Publication type:
- Article